270 related articles for article (PubMed ID: 23990173)
1. Chronic inflammation and cancer: suppressing the suppressors.
Baniyash M; Sade-Feldman M; Kanterman J
Cancer Immunol Immunother; 2014 Jan; 63(1):11-20. PubMed ID: 23990173
[TBL] [Abstract][Full Text] [Related]
2. Myeloid-derived suppressor cells as intruders and targets: clinical implications in cancer therapy.
Baniyash M
Cancer Immunol Immunother; 2016 Jul; 65(7):857-67. PubMed ID: 27225641
[TBL] [Abstract][Full Text] [Related]
3. Paving the Road to Tumor Development and Spreading: Myeloid-Derived Suppressor Cells are Ruling the Fate.
Meirow Y; Kanterman J; Baniyash M
Front Immunol; 2015; 6():523. PubMed ID: 26528286
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor-α blocks differentiation and enhances suppressive activity of immature myeloid cells during chronic inflammation.
Sade-Feldman M; Kanterman J; Ish-Shalom E; Elnekave M; Horwitz E; Baniyash M
Immunity; 2013 Mar; 38(3):541-54. PubMed ID: 23477736
[TBL] [Abstract][Full Text] [Related]
5. Myeloid-derived suppressor cells in cancer: therapeutic, predictive, and prognostic implications.
Diaz-Montero CM; Finke J; Montero AJ
Semin Oncol; 2014 Apr; 41(2):174-84. PubMed ID: 24787291
[TBL] [Abstract][Full Text] [Related]
6. Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity.
Movahedi K; Guilliams M; Van den Bossche J; Van den Bergh R; Gysemans C; Beschin A; De Baetselier P; Van Ginderachter JA
Blood; 2008 Apr; 111(8):4233-44. PubMed ID: 18272812
[TBL] [Abstract][Full Text] [Related]
7. Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor Microenvironment.
Parker KH; Beury DW; Ostrand-Rosenberg S
Adv Cancer Res; 2015; 128():95-139. PubMed ID: 26216631
[TBL] [Abstract][Full Text] [Related]
8. Activated human hepatic stellate cells induce myeloid derived suppressor cells from peripheral blood monocytes in a CD44-dependent fashion.
Höchst B; Schildberg FA; Sauerborn P; Gäbel YA; Gevensleben H; Goltz D; Heukamp LC; Türler A; Ballmaier M; Gieseke F; Müller I; Kalff J; Kurts C; Knolle PA; Diehl L
J Hepatol; 2013 Sep; 59(3):528-35. PubMed ID: 23665041
[TBL] [Abstract][Full Text] [Related]
9. Impaired SNX9 Expression in Immune Cells during Chronic Inflammation: Prognostic and Diagnostic Implications.
Ish-Shalom E; Meirow Y; Sade-Feldman M; Kanterman J; Wang L; Mizrahi O; Klieger Y; Baniyash M
J Immunol; 2016 Jan; 196(1):156-67. PubMed ID: 26608909
[TBL] [Abstract][Full Text] [Related]
10. Myeloid-derived suppressor cells participate in preventing graft rejection.
Wang Y; Gu X; Xiang J; Chen Z
Clin Dev Immunol; 2012; 2012():731486. PubMed ID: 22481970
[TBL] [Abstract][Full Text] [Related]
11. Phytochemicals inhibit the immunosuppressive functions of myeloid-derived suppressor cells (MDSC): Impact on cancer and age-related chronic inflammatory disorders.
Salminen A; Kaarniranta K; Kauppinen A
Int Immunopharmacol; 2018 Aug; 61():231-240. PubMed ID: 29894862
[TBL] [Abstract][Full Text] [Related]
12. Hampering immune suppressors: therapeutic targeting of myeloid-derived suppressor cells in cancer.
Albeituni SH; Ding C; Yan J
Cancer J; 2013; 19(6):490-501. PubMed ID: 24270348
[TBL] [Abstract][Full Text] [Related]
13. Myeloid-Derived Suppressor Cells as an Immune Parameter in Patients with Concurrent Sunitinib and Stereotactic Body Radiotherapy.
Chen HM; Ma G; Gildener-Leapman N; Eisenstein S; Coakley BA; Ozao J; Mandeli J; Divino C; Schwartz M; Sung M; Ferris R; Kao J; Wang LH; Pan PY; Ko EC; Chen SH
Clin Cancer Res; 2015 Sep; 21(18):4073-4085. PubMed ID: 25922428
[TBL] [Abstract][Full Text] [Related]
14. Myeloid-derived suppressor cells: linking inflammation and cancer.
Ostrand-Rosenberg S; Sinha P
J Immunol; 2009 Apr; 182(8):4499-506. PubMed ID: 19342621
[TBL] [Abstract][Full Text] [Related]
15. STAT3 Silencing and TLR7/8 Pathway Activation Repolarize and Suppress Myeloid-Derived Suppressor Cells From Breast Cancer Patients.
Safarzadeh E; Mohammadi A; Mansoori B; Duijf PHG; Hashemzadeh S; Khaze V; Kazemi T; Derakhshani A; Silvestris N; Baradaran B
Front Immunol; 2020; 11():613215. PubMed ID: 33679700
[TBL] [Abstract][Full Text] [Related]
16. Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model.
Meyer C; Sevko A; Ramacher M; Bazhin AV; Falk CS; Osen W; Borrello I; Kato M; Schadendorf D; Baniyash M; Umansky V
Proc Natl Acad Sci U S A; 2011 Oct; 108(41):17111-6. PubMed ID: 21969559
[TBL] [Abstract][Full Text] [Related]
17. Polysaccharide from Lentinus edodes inhibits the immunosuppressive function of myeloid-derived suppressor cells.
Wu H; Tao N; Liu X; Li X; Tang J; Ma C; Xu X; Shao H; Hou B; Wang H; Qin Z
PLoS One; 2012; 7(12):e51751. PubMed ID: 23272159
[TBL] [Abstract][Full Text] [Related]
18. Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015.
Ascierto PA; Agarwala S; Botti G; Cesano A; Ciliberto G; Davies MA; Demaria S; Dummer R; Eggermont AM; Ferrone S; Fu YX; Gajewski TF; Garbe C; Huber V; Khleif S; Krauthammer M; Lo RS; Masucci G; Palmieri G; Postow M; Puzanov I; Silk A; Spranger S; Stroncek DF; Tarhini A; Taube JM; Testori A; Wang E; Wargo JA; Yee C; Zarour H; Zitvogel L; Fox BA; Mozzillo N; Marincola FM; Thurin M
J Transl Med; 2016 Nov; 14(1):313. PubMed ID: 27846884
[TBL] [Abstract][Full Text] [Related]
19. Functional characterization of human Cd33+ and Cd11b+ myeloid-derived suppressor cell subsets induced from peripheral blood mononuclear cells co-cultured with a diverse set of human tumor cell lines.
Lechner MG; Megiel C; Russell SM; Bingham B; Arger N; Woo T; Epstein AL
J Transl Med; 2011 Jun; 9():90. PubMed ID: 21658270
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression.
Groth C; Hu X; Weber R; Fleming V; Altevogt P; Utikal J; Umansky V
Br J Cancer; 2019 Jan; 120(1):16-25. PubMed ID: 30413826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]